Sign In
Buy OM
$4.60
-0.470 (-9.27%)
At Close: Jun 03, 2026
2 No-Brainer Stocks to Buy Right Now for Less than $55
11:30am, Tuesday, 17'th May 2022
These companies have low share prices and high potential.
Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates
08:18pm, Wednesday, 04'th May 2022
Outset Medical, Inc. (OM) delivered earnings and revenue surprises of -1.52% and 0.65%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Why I'm Over the Moon for This Healthcare Stock -- In One Chart
07:55am, Wednesday, 27'th Apr 2022
This company helps keep patients at home with dialysis treatments.
Outset Medical to Report First Quarter 2022 Financial Results on Wednesday, May 4, 2022
04:05pm, Wednesday, 20'th Apr 2022
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysi
2 Medtech Stocks You Can Buy and Hold for the Next Decade
10:53am, Friday, 15'th Apr 2022
These two companies are leading the charge for improved patient outcomes.
2 No-Brainer Stocks to Buy Right Now for Less than $55
10:45am, Tuesday, 05'th Apr 2022
These two healthcare companies have bright futures -- and right now, two-digit price tags.
3 Biotechs That Will Crush the Bear
09:00pm, Friday, 11'th Mar 2022 The Motley Fool
Our roundtable likes Doximity, Outset Medical, and Pieris Pharmaceuticals to outperform in 2022.
3 Biotechs That Will Crush the Bear
04:00pm, Friday, 11'th Mar 2022
Our roundtable likes Doximity, Outset Medical, and Pieris Pharmaceuticals to outperform in 2022.
Outset Medical to Present at 42nd Annual Cowen Health Care Conference
04:05pm, Tuesday, 22'nd Feb 2022
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysi
Outset Medical stock soars 14% as Q4 revenue rises 63% Y/Y
05:36pm, Thursday, 17'th Feb 2022 Seeking Alpha
Outset Medical <> rose Feb. 17, after Q4 revenues grew ~63.2% Y/Y to $28.15M.The company also said that Leslie Trigg was appointed Chair of the board in addition to her ongoing role…
Outset Medical More Than Doubles Sales In FY21, Issues Better Than Expected FY22 Outlook
12:36pm, Thursday, 17'th Feb 2022 Benzinga
Outset Medical Inc (NASDAQ: OM ) recorded Q4 FY21 net revenue of $28.2 million , a 63.2%, beating the consensus of $26.42 million. Product revenue for the fourth quarter of 2021 was $23.7 million, +79.5%. The Company achieved a gross margin of 11.8%, compared to 2.4% in the fourth quarter of 2020 Select … Full story available on Benzinga.com
Outset Medical, Inc. (OM) Leslie Trigg on Q4 2021 Earnings Call Transcript
04:15am, Thursday, 17'th Feb 2022 Seeking AlphaOutset Medical, Inc. (OM) Leslie Trigg on Q4 2021 Earnings Call Transcript
11:15pm, Wednesday, 16'th Feb 2022
Outset Medical, Inc. (OM) Leslie Trigg on Q4 2021 Earnings Call Transcript
Outset Medical Reports Fourth Quarter and Full Year 2021 Financial Results
09:05pm, Wednesday, 16'th Feb 2022 Business Wire
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the fourth quarter and full year ended December 31, 2021. The Company also announced that Leslie Trigg has been appointed Chair of the Board of Directors in addition to her ongoing role as President and Chief Executive Officer. Recent Highlights
Outset Medical, Inc. (OM) Reports Q4 Loss, Tops Revenue Estimates
08:04pm, Wednesday, 16'th Feb 2022
Outset Medical, Inc. (OM) delivered earnings and revenue surprises of -14.93% and 6.04%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
